Intarcia Therapeutics

Intarcia Therapeutics is a rapidly emerging biopharmaceutical company committed to developing innovative therapies utilizing the Medici Drug Delivery System™ – medicines that have the potential to transform the prevention and management of serious chronic diseases. The Company’s near-term goal is to deliver a game-changing new level of glycemic control for a vast number of patients with type 2 diabetes with a longer-term goal of expanding its Medici Drug Delivery System.